Anthony J. Polverino Insider Trading
Get free email notifications about insider trading for Anthony J. Polverino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony J. Polverino. Anthony J. Polverino is a Director in BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) and a Chief Scientific Officer in Zymeworks Inc. ($ZYME).
Address: C/O BRAINSTORM CELL THERAPEUTICS INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK 07601 NJ
Companies in which Anthony J. Polverino is an Insider
BRAINSTORM CELL THERAPEUTICS INC.
Trading Symbol: BCLIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony J. Polverino: Director
Holdings: 12,791 shares
Current Value: $41,187
Latest Transaction: Feb 14 2020
$BCLI Market Capitalization: $60.17M
$BCLI Previous Close: $3.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zymeworks Inc.
Trading Symbol: ZYMEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony J. Polverino: Chief Scientific Officer
Holdings: 32,027 shares
Latest Transaction: Mar 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Anthony J. Polverino
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 34.82 | 48,750 | 1,697,475 | 48,750 | |
Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Sell | S | 34.95 | 1,048 | 36,631 | 30,979 | 32 K to 31 K (-3.27 %) |
Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Buy | M | 0.00 | 2,500 | 0 | 32,027 | 29.5 K to 32 K (+8.47 %) |
Jan 11 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.92 | 48 | 1,484 | 29,527 | 29.5 K to 29.5 K (+0.16 %) |
Jul 06 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.66 | 488 | 14,962 | 29,479 | 29 K to 29.5 K (+1.68 %) |